SCHEMBL14722952

SCHEMBL14722952

O=c1c(C(F)(F)F)cccn1Cc1ccc(C=C2CCN(C3CCC3)CC2)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV6 Q9H1D0 2/20 0.38
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 4/20 0.38
POLB P06746 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
MAPT P10636 2/20 0.36
TP53 P04637 1/20 0.36
CNR1 P21554 2/20 0.35
CNR2 P34972 2/20 0.35
IL4I1 Q96RQ9 1/20 0.35
RORC P51449 1/20 0.35
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HCRTR1 O43613 2/20 0.34
HCRTR2 O43614 2/20 0.34
HRH3 Q9Y5N1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14721926 0.85 POLB (0.39) KDM4EALDH1A1POLBSMN1; SMN2MAPT
SCHEMBL14722283 0.83 LMNA (0.41) KDM4EALDH1A1MAPTTP53CNR1
SCHEMBL14722538 0.82 POLB (0.36) TRPV6POLBSMN1; SMN2HRH3
SCHEMBL14720463 0.74 L3MBTL1 (0.47) ALDH1A1CYP1A2CYP2C9HRH3
SCHEMBL14721179 0.74 L3MBTL1 (0.50) CYP1A2CYP2C9HRH3
SCHEMBL14721908 0.73 HRH3 (0.36) POLBHRH3
SCHEMBL14720575 0.73 L3MBTL3 (0.51) KDM4EALDH1A1CYP2C19HRH3
SCHEMBL14720592 0.72 HRH3 (0.35) KDM4EALDH1A1HRH3
SCHEMBL14722442 0.71 GRM2 (0.47) SMN1; SMN2MAPTHRH3
SCHEMBL14720649 0.71 FKBP1A (0.35) ALDH1A1SMN1; SMN2TP53HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO claimed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed
WO-2013027001-A1 COMPOUNDS AND THEIR USE TO TREAT HISTAMINE H3 RELATED DISORDERS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-02-28 WO disclosed